SCHEMBL7011578

SCHEMBL7011578

Cc1ccc(Oc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
C5AR1 P21730 1/20 0.49
PTGER1 P34995 2/20 0.47
PTGER4 P35408 2/20 0.47
PTGER3 P43115 2/20 0.47
PTGER2 P43116 2/20 0.47
MRGPRX4 Q96LA9 3/20 0.47
MAOB P27338 3/20 0.46
TTR P02766 1/20 0.45
FFAR4 Q5NUL3 3/20 0.45
FFAR1 O14842 2/20 0.45
STAT3 P40763 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ABCB1 P08183 1/20 0.43
HTR1A P08908 1/20 0.43
DRD2 P14416 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL686650 0.88 MAPT (0.58) MAPTMAPK1TDP1L3MBTL1C5AR1
SCHEMBL827943 0.83 SMPD1 (0.57) MAPTMAPK1TDP1L3MBTL1MRGPRX4
SCHEMBL16118592 0.83 MAPT (0.53) MAPTTDP1L3MBTL1TTR
SCHEMBL5682468 0.83 L3MBTL1 (0.58) MAPTMAPK1TDP1L3MBTL1C5AR1
SCHEMBL13799708 0.82 TTR (0.47) MAPK1TDP1L3MBTL1TTRHTT
SCHEMBL12584881 0.82 KDM4E (0.57) MAPTMAPK1TDP1L3MBTL1PTGER1
SCHEMBL13296740 0.81 FFAR1 (0.44) C5AR1MAOBTTRFFAR4FFAR1
SCHEMBL30744016 0.81 MAOB (0.58) MAPTMAPK1TDP1L3MBTL1C5AR1
SCHEMBL21295357 0.81 MAOB (0.58) MAPTMAPK1TDP1L3MBTL1C5AR1
SCHEMBL130824 0.80 MRGPRX4 (0.68) MAPTMAPK1TDP1L3MBTL1PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268502-A1 O-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2003-01-02 EP disclosed
WO-2001074834-A1 O-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2001-10-11 WO disclosed